Goldman Sachs’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.4M Buy
2,583,046
+69,865
+3% +$752K ﹤0.01% 2033
2026
Q1
$21.3M Buy
2,513,181
+550,975
+28% +$6.03M ﹤0.01% 2376
2025
Q4
$22.2M Buy
1,962,206
+383,816
+24% +$4.76M ﹤0.01% 2283
2025
Q3
$23.7M Buy
1,578,390
+598,473
+61% +$8.71M ﹤0.01% 2103
2025
Q2
$13.8M Buy
979,917
+175,991
+22% +$3.14M ﹤0.01% 2464
2025
Q1
$19.3M Sell
803,926
-12,897
-2% -$455K ﹤0.01% 2064
2024
Q4
$30.5M Buy
816,823
+174,447
+27% +$8.14M ﹤0.01% 1724
2024
Q3
$32.1M Sell
642,376
-86,783
-12% -$3.38M 0.01% 1629
2024
Q2
$25.3M Sell
729,159
-211,275
-22% -$8.35M ﹤0.01% 1694
2024
Q1
$51.4M Sell
940,434
-5,281
-0.6% -$261K 0.01% 1148
2023
Q4
$40.5M Buy
945,715
+71,850
+8% +$2.23M 0.01% 1330
2023
Q3
$22.7M Buy
873,865
+114,889
+15% +$2.39M ﹤0.01% 1678
2023
Q2
$18.2M Buy
758,976
+343,482
+83% +$5.91M ﹤0.01% 1934
2023
Q1
$5.68M Sell
415,494
-309,388
-43% -$4.92M ﹤0.01% 2945
2022
Q4
$10.1M Buy
+724,882
New +$10.2M ﹤0.01% 2584

Other funds holding BHVN

Goldman Sachs's BHVN Position: Q2 2026 in Review

Goldman Sachs increased its Biohaven (BHVN) stake by 2.8% in Q2 2026, buying an estimated $752K and bringing the position to 2,583,046 shares worth $38.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2033.

Goldman Sachs first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $51.4M in Q1 2024. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Goldman Sachs held 2,583,046 shares of Biohaven worth $38.4M as of Q2 2026.
  • Goldman Sachs bought 69,865 Biohaven shares in Q2 2026, an estimated $752K.
  • Biohaven made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2033 holding.
  • Goldman Sachs first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Goldman Sachs's Biohaven position peaked at $51.4M in Q1 2024.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.